"Daily food intake provides the necessary energy to fuel our bodies. However, these nutrients can produce complimentary tasks as they interact with our genes," says Dr. Levy. "Nutrigenomics is a new research avenue that promises to reduce the impact of cardiovascular diseases and other disorders by charting healthier eating habits that reduce the vulnerability of people who are genetically predisposed. Nutrigenomics will couple prevention and nutrition to decrease medical interventions."
Nanosuspensions to improve pharmaceuticals
Dr. Grgoire Leclair, a professor at the Universit de Montral's Faculty of Pharmacy, has received $156,208 in CFI support; $156,209 from the Government of Quebec and $78,104 from the private sector for a total of $ 390,520. He will investigate ways to improve pharmaceuticals using a nanosuspension platform technology, which involves the production of drug particles that are one millionth of a millimetre.
"Nanosuspension production is a water-based process that does not involve the use of organic solvents. It allows the formulation of drugs that could otherwise not be absorbed by the digestive system," says Dr. Leclair. "Using a nanosuspension-based formulation, medications can be swallowed, inhaled, injected or applied topically. This CFI funding will allow the Universit de Montral to develop new platform technologies to improve the formulation of existing medications and accelerate the development of new chemically
|Contact: Sylvain-Jacques Desjardins|
University of Montreal